The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1014
November 21, 1997
View Complete Issue         Table of Contents 2019 
Olopatadine for Allergic Conjunctivitis
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Olopatadine for Allergic Conjunctivitis
November 21, 1997 (Issue: 1014)
Olopatadine hydrochloride (Patanol - Alcon), a propilidinedibenzoxypin derivative, has recently been marketed in a 0.1% ophthalmic solution for prevention of itching due to allergic conjunctivitis in adults and children more than three years old....more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Olopatadine for Allergic Conjunctivitis
Article code: 1014b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.